Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

A patient's grey hair regained color during treatment with adalimumab.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Setipiprant did not significantly improve hair growth in men with hair loss.

A new microneedle system with minoxidil nanoparticles effectively promotes hair regrowth with fewer side effects.

Ayurveda can help treat premature hair graying with lifestyle changes and herbal remedies.

IGF-1R may play a role in female hair loss and could be a treatment target.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

New UVA-responsive nanocapsules effectively kill microorganisms in hair follicles when activated by light.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

A method was found to accurately measure spironolactone and canrenone in blood samples using liquid chromatography-mass spectrometry.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Poliosis circumscripta is a patch of white hair caused by lack of melanin, linked to genetic and acquired conditions.